Intrepid Potash (IPI)
Q4 2011 Earnings Call
February 16, 2012 10:00 am ET
William Kent -
Robert P. Jornayvaz - Co-Founder, Executive Chairman of The Board and Principal Executive Officer
Kelvin G. Feist - Vice President of Marketing & Sales
David W. Honeyfield - President and Chief Financial Officer
Kurt Schoen - Credit Agricole Securities (USA) Inc., Research Division
Bill Carroll - UBS Investment Bank, Research Division
Elaine Yip - Crédit Suisse AG, Research Division
Lindsay Mann - Goldman Sachs Group Inc., Research Division
Joel Jackson - BMO Capital Markets Canada
Farooq Hamed - Barclays Capital, Research Division
Good morning, and welcome to the Intrepid Potash Fourth Quarter and Year End 2011 Earnings Conference Call. [Operator Instructions] I would like to remind everyone that this conference is being recorded today, Thursday, February 16, 2012, at 8:00 a.m. Mountain Time. It is my pleasure to turn the conference over to William Kent, Director of Investor Relations. Mr. Kent, please go ahead.
Good morning. Thank you, Joe, and thank you all for joining us today for our fourth quarter and year end 2011 earnings conference call. Participants from the company include Bob Jornayvaz, Executive Chairman of the Board; David Honeyfield, President and Chief Financial Officer; Martin Litt, Executive Vice President, General Counsel and Secretary; Kelvin Feist, Senior Vice President of Marketing and Sales; and John Mansanti, Senior Vice President of Operations.
I would like to remind everyone that statements made on this call that are not historical fact or that express a belief, expectation or intention, including statements about our financial and operational outlook, are forward-looking statements within the meaning of the United States securities laws. These statements are not guarantees of future performance. A number of assumptions, which we believe are reasonable, were made in connection with the expectations reflected in such forward-looking statements. The forward-looking statements involve risks and uncertainties, which could cause actual results to differ from our expectations.